The recommendations for surveillance account for newly identified hematopoietic malignancy predispositions (HMP) and HMP ...

Mays Cancer Center at The University of Texas Health Science Center at San Antonio (UT Health San Antonio), in partnership with the American Association for Cancer Research (AACR), is hosting the 47th ...

NeoGenomics will present research on hematologic malignancies and the prognostic effects of microenvironment signatures in ...

SAN DIEGO — Pfizer’s abrupt withdrawal of its sickle cell drug Oxybryta over safety concerns was called “tone deaf” during a ...

The publisher has been closely monitoring the various markets in Saudi Arabia. This report provides a comprehensive analysis, detailing market size, forecast, trends, growth drivers, and challenges.

Hematologists and oncologists from around the world will present new research and clinical findings at the American Society of Hematology’s (ASH) 66th Annual Meeting and Exposition. This year’s ...

Sharf, MD, and colleagues will discuss treatment considerations in metastatic ER+ breast cancer at the 2024 SABCS meeting.

PharmaEssentia Corporation (TWSE: 6446), a global biopharmaceutical innovator based in Taiwan leveraging deep expertise and proven scientific principles to deliver new biologics in hematology and ...

On the basis of technique, it is categorized into immunodiagnostics, hematology, molecular diagnostics ... The clinical chemistry segment is also further divided basic metabolic panel, liver panel, ...

An international panel of experts recently agreed on the most current recommendations for treating and managing HDFN. The ...

Early disease detection is beneficial for securing the best possible outcomes for patients. But finding noninvasive, effective ways to predict disease risk is a tremendous challenge.